
Addison D. Ault
Examiner (ID: 17024, Phone: (571)270-7028 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636 |
| Total Applications | 403 |
| Issued Applications | 199 |
| Pending Applications | 3 |
| Abandoned Applications | 201 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6007826
[patent_doc_number] => 20110059857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'MARKERS OF ACUTE KIDNEY FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/937716
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9822
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937716 | Markers of acute kidney failure | Apr 14, 2009 | Issued |
Array
(
[id] => 6025698
[patent_doc_number] => 20110053804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Gene Signatures for the Prognosis of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/935224
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13653
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935224 | Gene Signatures for the Prognosis of Cancer | Apr 2, 2009 | Abandoned |
Array
(
[id] => 8772612
[patent_doc_number] => 08426569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'DNA capable of being amplified by PCR with high selectivity and high efficiency'
[patent_app_type] => utility
[patent_app_number] => 12/934066
[patent_app_country] => US
[patent_app_date] => 2009-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17177
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12934066
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934066 | DNA capable of being amplified by PCR with high selectivity and high efficiency | Mar 30, 2009 | Issued |
Array
(
[id] => 5374134
[patent_doc_number] => 20090311695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Method'
[patent_app_type] => utility
[patent_app_number] => 12/403092
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19239
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403092 | Method | Mar 11, 2009 | Abandoned |
Array
(
[id] => 8328435
[patent_doc_number] => 08236527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Recombinant production of authentic human proteins using human cell expression systems'
[patent_app_type] => utility
[patent_app_number] => 12/922293
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 30582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922293 | Recombinant production of authentic human proteins using human cell expression systems | Mar 11, 2009 | Issued |
Array
(
[id] => 9312031
[patent_doc_number] => 08653249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/918776
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10062
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918776
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918776 | Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof | Feb 26, 2009 | Issued |
Array
(
[id] => 6189700
[patent_doc_number] => 20110172112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Combination of Marker Genes for Characterizing a Lactobacillus Sakei Strain'
[patent_app_type] => utility
[patent_app_number] => 12/920057
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15266
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172112.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920057
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920057 | Combination of marker genes for characterizing a Lactobacillus sakei strain | Feb 19, 2009 | Issued |
Array
(
[id] => 7663264
[patent_doc_number] => 20110312533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'CELL LINES EXPRESSING NaV AND METHODS OF USING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/147333
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19351
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312533.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147333
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147333 | CELL LINES EXPRESSING NaV AND METHODS OF USING THEM | Feb 1, 2009 | Abandoned |
Array
(
[id] => 6097329
[patent_doc_number] => 20110003711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'CELL LINES EXPRESSING GABA RECEPTOR AND METHODS USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/865497
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 32225
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865497 | CELL LINES EXPRESSING GABA RECEPTOR AND METHODS USING THEM | Feb 1, 2009 | Abandoned |
Array
(
[id] => 6628825
[patent_doc_number] => 20100311610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended)'
[patent_app_type] => utility
[patent_app_number] => 12/865439
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54972
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865439 | CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended) | Feb 1, 2009 | Abandoned |
Array
(
[id] => 5379795
[patent_doc_number] => 20090191634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => '(METH)ACRYLATE SURFACES FOR CELL CULTURE, METHODS OF MAKING AND USING THE SURFACES'
[patent_app_type] => utility
[patent_app_number] => 12/362756
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9702
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191634.pdf
[firstpage_image] =>[orig_patent_app_number] => 12362756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/362756 | (METH)ACRYLATE SURFACES FOR CELL CULTURE, METHODS OF MAKING AND USING THE SURFACES | Jan 29, 2009 | Abandoned |
Array
(
[id] => 6002649
[patent_doc_number] => 20110118131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'METHODS AND MATERIALS FOR TARGETED MUTAGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/811331
[patent_app_country] => US
[patent_app_date] => 2008-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 29273
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811331 | Methods and materials for targeted mutagenesis | Dec 30, 2008 | Issued |
Array
(
[id] => 6236022
[patent_doc_number] => 20100267571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'NOVEL METHOD FOR SPECIMEN PREPARATION, WHICH ENSURES PRESERVATION OF TISSUE MORPHOLOGY AND NUCLEIC ACID QUALITY'
[patent_app_type] => utility
[patent_app_number] => 12/808142
[patent_app_country] => US
[patent_app_date] => 2008-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7313
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267571.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808142 | NOVEL METHOD FOR SPECIMEN PREPARATION, WHICH ENSURES PRESERVATION OF TISSUE MORPHOLOGY AND NUCLEIC ACID QUALITY | Dec 14, 2008 | Abandoned |
Array
(
[id] => 6574335
[patent_doc_number] => 20100273666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'METHODS OF ANALYZING WOUND SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 12/747687
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14381
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273666.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747687
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747687 | METHODS OF ANALYZING WOUND SAMPLES | Dec 9, 2008 | Abandoned |
Array
(
[id] => 6161653
[patent_doc_number] => 20110159586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION USING ASYMMETRICALLY-ACTIVE PRECURSOR POLYNUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/746153
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14710
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746153 | COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION USING ASYMMETRICALLY-ACTIVE PRECURSOR POLYNUCLEOTIDES | Dec 7, 2008 | Abandoned |
Array
(
[id] => 9227343
[patent_doc_number] => 08633010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Fungal PepC inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/742545
[patent_app_country] => US
[patent_app_date] => 2008-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15102
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742545 | Fungal PepC inhibitor | Dec 1, 2008 | Issued |
Array
(
[id] => 6632039
[patent_doc_number] => 20100311816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MCP-1 binding nucleic acids and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/745545
[patent_app_country] => US
[patent_app_date] => 2008-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 49742
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 59
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311816.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745545 | MCP-1 binding nucleic acids and use thereof | Nov 28, 2008 | Abandoned |
Array
(
[id] => 7663274
[patent_doc_number] => 20110312543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Expression Vectors Based on Modified Ribosomal Protein Promoters and Uses Thereof in Post-Transcriptional Assessment'
[patent_app_type] => utility
[patent_app_number] => 13/000556
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12227
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312543.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000556
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000556 | Expression vectors based on modified ribosomal protein promoters and uses thereof in post-transcriptional assessment | Nov 16, 2008 | Issued |
Array
(
[id] => 7733185
[patent_doc_number] => 20120015827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHOD FOR THERAPY PREDICTION IN TUMORS HAVING IRREGULARITIES IN THE EXPRESSION OF AT LEAST ONE VEGF LIGAND AND/OR AT LEAST ONE ERBB-RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/745620
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14672
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015827.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745620
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745620 | METHOD FOR THERAPY PREDICTION IN TUMORS HAVING IRREGULARITIES IN THE EXPRESSION OF AT LEAST ONE VEGF LIGAND AND/OR AT LEAST ONE ERBB-RECEPTOR | Nov 9, 2008 | Abandoned |
Array
(
[id] => 6347269
[patent_doc_number] => 20100330614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'GLOBAL TRANSCRIPTION MACHINERY ENGINEERING TARGETING THE RNAP ALPHA SUBUNIT (RPOA)'
[patent_app_type] => utility
[patent_app_number] => 12/741750
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21525
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741750
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741750 | GLOBAL TRANSCRIPTION MACHINERY ENGINEERING TARGETING THE RNAP ALPHA SUBUNIT (RPOA) | Nov 5, 2008 | Abandoned |